Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.50    -0.20 (-7.41%)
Bid:
2.50
Ask:
2.66
Spread: 0.16 (6.40%)
Market Cap: £2.58m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Dividend Date

17 Sep 2024 18:05

RNS Number : 5878E
Litigation Capital Management Ltd
17 September 2024
 

17 September 2024

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Dividend Date

 

Litigation Capital Management Limited is clarifying today's dividend declaration in its full year results, correctly stated in the 2024 Annual Report and Accounts but misstated in the 'Full year audited results for the year ended 30 June 2024' RNS.

 

The Board has declared a final dividend of 1.25p per share for the financial year ending 30 June 2024 (FY23: 2.25p). The dividend will be paid on 25 October 2024 to shareholders on the register on 4 October 2024, being the record date. The ordinary shares will be marked ex-dividend on 3 October 2024.

Enquiries

 

Litigation Capital Management

c/o Tavistock

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Andrew Potts

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Tavistock (PR and IR)

Tel: 020 7920 3150

Simon Hudson

Katie Hopkins

lcm@tavistock.co.uk

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its income from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVSFUFMWELSEIU
Date   Source Headline
28th Mar 20191:32 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSGlobal cooperation agreement with law firm
20th Mar 20199:56 amRNSSettlement in principle of litigation project
8th Mar 20197:00 amRNSJSOP Award
7th Mar 20195:08 pmRNSAppointment of Jonathan Moulds as Chairman
4th Mar 20197:00 amRNSHalf-year Report
20th Feb 20198:00 amRNSNotice of Results
18th Feb 201912:05 pmRNSHolding(s) in Company
15th Feb 20197:00 amRNSHolding(s) in Company
6th Feb 201910:44 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSNew litigation project
21st Dec 20181:08 pmRNSHolding(s) in Company
21st Dec 20187:30 amRNSHolding(s) in Company
21st Dec 20187:01 amRNSSettlement of litigation project
21st Dec 20187:00 amRNSCompletion of delisting from ASX
19th Dec 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.